CytoDyn Sees Promising Early Responses in Two Breast Cancer Patients to Leronlimab

The results arose from a PhaseIb/II trial investigating new drug candidate leronlimab for the treatment of metastatic triple-negative breast cancer.

Read the full article here

Related Articles